Related references
Note: Only part of the references are listed.Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Eda Kaya et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)
Olfactomedin 2 deficiency protects against diet-induced obesity
Ismael Gonzalez-Garcia et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Orsolya Inczefi et al.
FRONTIERS IN NUTRITION (2022)
Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Benedikt Kaufmann et al.
LANGENBECKS ARCHIVES OF SURGERY (2021)
TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
Christopher R. Shepard
FRONTIERS IN ENDOCRINOLOGY (2021)
NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet
P. Vineeth Daniel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
Hao Xu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
Laia Bertran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pathology of non-alcoholic fatty liver disease
Ivana Cataldo et al.
PATHOLOGICA (2021)
New targets for NAFLD
Lucia Parlati et al.
JHEP REPORTS (2021)
NASH-related increases in plasma bile acid levels depend on insulin resistance
Guillaume Grzych et al.
JHEP REPORTS (2021)
Toll-like receptor 5-mediated signaling enhances liver regeneration in mice
Wen Zhang et al.
MILITARY MEDICAL RESEARCH (2021)
Circulating microbiota-derived metabolites: a liquid biopsy?
Gemma Aragones et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Jose Maria G. Ruiz de Morales et al.
AUTOIMMUNITY REVIEWS (2020)
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
Vian Azzu et al.
GASTROENTEROLOGY (2020)
Hepatocyte Notch Signaling Deregulation Related to Lipid Metabolism in Women with Obesity and Nonalcoholic Fatty Liver
Teresa Auguet et al.
OBESITY (2020)
Reviews in endocrine and metabolic disorders
Silvia Bettini et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission
Priscila Sala et al.
NUTRITION (2020)
MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
Yong He et al.
HEPATOLOGY (2019)
Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease
Xuying Tan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
BCL6 regulates brown adipocyte dormancy to maintain thermogenic reserve and fitness
Vassily I. Kutyavin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
Giovanna Muscogiuri et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
Ivana Milosevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis
Vignan Manne et al.
CLINICS IN LIVER DISEASE (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Olfactomedin-4 in digestive diseases: A mini-review
Xin-Yu Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Marcelo Macedo Rogero et al.
NUTRIENTS (2018)
Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Oliver Glass et al.
HEPATOLOGY COMMUNICATIONS (2018)
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina et al.
DRUG METABOLISM REVIEWS (2017)
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M. Pappachan et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer
Wenli Liu et al.
CANCER AND METASTASIS REVIEWS (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice
W. Liu et al.
ONCOGENE (2016)
Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
Yuan Tian et al.
CANCERS (2016)
Deletion of the Toll-Like Receptor 5 Gene Per Se Does Not Determine the Gut Microbiome Profile That Induces Metabolic Syndrome: Environment Trumps Genotype
Wei Zhang et al.
PLOS ONE (2016)
Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
Yu-ming Chen et al.
SCIENTIFIC REPORTS (2016)
The intestinal microbiota and its role in human health and disease
Keiko Kataoka
JOURNAL OF MEDICAL INVESTIGATION (2016)
Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease
Lucie Etienne-Mesmin et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)
Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression
Darkiane Fernandes Ferreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Intestinal Epithelial Cell Toll-like Receptor 5 Regulates the Intestinal Microbiota to Prevent Low-Grade Inflammation and Metabolic Syndrome in Mice
Benoit Chassaing et al.
GASTROENTEROLOGY (2014)
Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
Teresa Auguet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Xiang Gao et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
The Gut-Adipose-Liver Axis in the Metabolic Syndrome
Daniel Konrad et al.
PHYSIOLOGY (2014)
Microbiota and nonalcoholic steatohepatitis
Kento Imajo et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Kouichi Miura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Olfactomedin proteins: central players in development and disease
Robert R. H. Anholt
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells
Kelli L. VanDussen et al.
DEVELOPMENT (2012)
Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis
Phulwinder K. Grover et al.
CANCER AND METASTASIS REVIEWS (2010)
Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection
Wenli Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Matam Vijay-Kumar et al.
SCIENCE (2010)
Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease
Makoto Nakamuta et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
Olfactomedin Domain-Containing Proteins: Possible Mechanisms of Action and Functions in Normal Development and Pathology
Stanislav I. Tomarev et al.
MOLECULAR NEUROBIOLOGY (2009)
Hepatic microcirculation in fatty liver disease
Geoff C. Farrell et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
The regulation of OLFM4 expression in myeloid precursor cells relies on NF-κB transcription factor
Kyung L. Chin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Dennys E. Cintra et al.
JOURNAL OF HEPATOLOGY (2008)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of hGC-1 is correlated with differentiation of gastric carcinoma
W. Liu et al.
HISTOPATHOLOGY (2007)
The glycoprotein hGC-1 binds to cadherin and lectins
Wenli Liu et al.
EXPERIMENTAL CELL RESEARCH (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Association of low interleukin-10 levels with the metabolic syndrome in obese women
K Esposito et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development
JC Zhang et al.
GENE (2002)
Anti-inflammatory mechanisms in the vascular wall
A Tedgui et al.
CIRCULATION RESEARCH (2001)
Share Paper
